Changes in elderly women's health-related quality of life following discontinuation of hormone replacement therapy

作者: Debra A Heller , Carol H Gold , Frank M Ahern , Kristine E Pringle , Theresa V Brown

DOI: 10.1186/1472-6874-5-7

关键词: Hormone replacement therapy (female-to-male)Propensity score matchingReproductive medicineMedicineMedical prescriptionMental healthDiscontinuationBehavioral Risk Factor Surveillance SystemGynecologyInternal medicineQuality of life

摘要: Many women have discontinued hormone replacement therapy (HRT) in view of recent findings. The goal this study was to determine if HRT discontinuation is associated with changes health-related quality life (HRQOL) elderly women. We studied enrolled Pennsylvania's Pharmaceutical Assistance Contract for the Elderly (PACE) program, linking prescription claims data from a longitudinal mail survey. HRQOL measures included number days out last 30 that physical health not good and analogous mental health, pain, interference activities, as well composite "healthy days" measure developed by CDC. Longitudinal analyses focused on 2,357 who completed surveys both 2002 2003, used at baseline (mean age = 75.5, range 65–102). Propensity scores were match continuers discontinuers according type, demographics, HRQOL. Analysis covariance compare change discontinuers. Between 43% users therapy. examine revealed complex interactions age. Discontinuers aged 65–74 reported greater increases which (p < .05), fewer more interfered activities .01), pain .01). Among 75–84, .01); no other significant effects observed group. Relative continuers, 85 older experienced apparent improvements following cessation, poor These results suggest there are substantial differences response discontinuation. While declines relative improvements. among younger underscore importance communication between clinicians patients throughout process. also demonstrate value surveillance component program administration.

参考文章(33)
D Chan, L W Chambers, S Ounpuu, S Yusuf, Validity of the US Behavioral Risk Factor Surveillance System's health related quality of life survey tool in a group of older Canadians. Chronic Diseases in Canada. ,vol. 22, pp. 93- 101 ,(2001)
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
JoAnn E. Manson, Judith Hsia, Karen C. Johnson, Jacques E. Rossouw, Annlouise R. Assaf, Norman L. Lasser, Maurizio Trevisan, Henry R. Black, Susan R. Heckbert, Robert Detrano, Ora L. Strickland, Nathan D. Wong, John R. Crouse, Evan Stein, Mary Cushman, Estrogen plus Progestin and the Risk of Coronary Heart Disease New England Journal of Medicine. ,vol. 349, pp. 523- 534 ,(2003) , 10.1056/NEJMOA030808
Adam L. Hersh, Marcia L. Stefanick, Randall S. Stafford, National Use of Postmenopausal Hormone Therapy JAMA. ,vol. 291, pp. 47- 53 ,(2004) , 10.1001/JAMA.291.1.47
Mark A. Hlatky, Derek Boothroyd, Eric Vittinghoff, Penny Sharp, Mary A. Whooley, for the HERS Research Group, Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy JAMA. ,vol. 287, pp. 591- 597 ,(2002) , 10.1001/JAMA.287.5.591
Kimberly A Brownley, Alan L Hinderliter, Sheila G West, Karen M Grewen, John F Steege, Susan S Girdler, Kathleen C Light, Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause. American Journal of Obstetrics and Gynecology. ,vol. 190, pp. 1052- 1058 ,(2004) , 10.1016/J.AJOG.2003.09.045
Mary A. Whooley, , Deborah Grady, Jane A. Cauley, Postmenopausal estrogen therapy and depressive symptoms in older women. Journal of General Internal Medicine. ,vol. 15, pp. 535- 541 ,(2000) , 10.1046/J.1525-1497.2000.04029.X